Tango Therapeutics, Inc. TNGX
$24.24
-0.86%
at last close
Analyst Consensus
- Consensus Rating
- Buy (10 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $43.18
- Implied Upside
- +78.1%
- Price Target Range
- $14.00 – $69.00
- Analysts (12 mo)
- 12
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-18 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $66 → $68 |
| 2026-08-12 | GuggenheimMichael Schmidt |
Maintains | Buy | $32 → $35 |
| 2026-07-17 | MizuhoJoseph Catanzaro |
Maintains | Outperform | $36 → $40 |
| 2026-07-15 | JP MorganBrian Cheng |
Initiates coverage on | Overweight | $46 |
| 2026-06-29 | Canaccord GenuityJohn Newman |
Maintains | Buy | $42 → $46 |
| 2026-06-26 | JefferiesMaury Raycroft |
Upgrades | Hold → Buy | $27 → $60 |
| 2026-06-11 | Canaccord GenuityJohn Newman |
Maintains | Buy | $42 |
| 2026-06-09 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $27 → $66 |
| 2026-06-09 | Canaccord GenuityJohn Newman |
Maintains | Buy | $30 → $42 |
| 2026-06-08 | Leerink PartnersAndrew Berens |
Maintains | Outperform | $55 → $69 |
| 2026-05-15 | MizuhoJoseph Catanzaro |
Maintains | Outperform | $20 → $30 |
| 2026-05-15 | Piper SandlerKelsey Goodwin |
Downgrades | Overweight → Neutral | $16 → $24 |
| 2026-05-14 | JefferiesMaury Raycroft |
Downgrades | Buy → Hold | $18 → $27 |
| 2026-05-14 | Leerink PartnersAndrew Berens |
Maintains | Outperform | $28 → $55 |
| 2026-05-14 | WedbushRobert Driscoll |
Maintains | Outperform | $19 → $33 |
| 2026-04-27 | StifelLaura Prendergast |
Maintains | Buy | $24 → $40 |
| 2026-04-02 | Canaccord GenuityJohn Newman |
Initiates coverage on | Buy | $30 |
| 2026-03-11 | MizuhoJoseph Catanzaro |
Maintains | Outperform | $19 → $20 |
| 2026-03-09 | StifelLaura Prendergast |
Maintains | Buy | $15 → $24 |
| 2026-03-06 | WedbushRobert Driscoll |
Maintains | Outperform | $15 → $19 |
| 2026-03-06 | GuggenheimMichael Schmidt |
Maintains | Buy | $18 → $20 |
| 2026-03-06 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $13 → $27 |
| 2026-02-23 | MizuhoJoseph Catanzaro |
Initiates coverage on | Outperform | $19 |
| 2026-02-06 | GuggenheimMichael Schmidt |
Maintains | Buy | $12 → $18 |
| 2026-01-16 | Piper SandlerKelsey Goodwin |
Maintains | Overweight | $11 → $14 |
| 2025-12-04 | StifelLaura Prendergast |
Initiates coverage on | Buy | $15 |
| 2025-11-18 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Peer perform | — |
| 2025-11-18 | B. Riley SecuritiesYuan Zhi |
Maintains | Buy | $8 → $14 |
| 2025-10-24 | GuggenheimCharles Zhu |
Maintains | Buy | $10 → $12 |
| 2025-08-19 | Piper SandlerKelsey Goodwin |
Initiates coverage on | Overweight | $11 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $24.24
- Market Cap
- $4.12 billion
- 52-Week Range
- $6.25 – $34.39
- Average Volume
- 2.74 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.